Summary
Cardinal Health, Inc. (CAH) reported its financial results for the second quarter and first half of fiscal year 2003, ending December 31, 2002. The company demonstrated robust top-line growth, with operating revenue increasing by 13% and 14% for the three and six-month periods, respectively, driven by strong performance across its Pharmaceutical Distribution and Provider Services, Medical Products and Services, Pharmaceutical Technologies and Services, and Automation and Information Services segments. Net earnings saw a significant increase year-over-year, benefiting from operational efficiencies, revenue growth, and a substantial one-time gain from litigation settlements. The company continued its strategic initiatives, including ongoing integration of past acquisitions and proactive management of its operational footprint through facility consolidations. Despite these integration costs and other special items, the underlying operational performance remained strong. Management highlighted positive trends in gross margins for its Pharmaceutical Technologies and Services and Automation and Information Services segments, indicating successful margin expansion strategies in these areas. The company also continued its share repurchase program, demonstrating a commitment to returning value to shareholders.
Key Highlights
- 1Total operating revenue grew by 13% to $12.7 billion for the three months ended December 31, 2002, and by 14% to $24.1 billion for the six months ended December 31, 2002, compared to the prior year periods.
- 2Net earnings for the three months ended December 31, 2002, were $367.5 million, or $0.82 per diluted share, a significant increase from $283.3 million, or $0.62 per diluted share, in the prior year.
- 3The company recorded $89.9 million in litigation settlement income during the three months ended December 31, 2002, related to antitrust claims against vitamin manufacturers, positively impacting net earnings.
- 4Special items, including merger-related costs and facility closures, totaled $37.6 million in charges for the quarter. However, the net effect of all special items was a $22.1 million increase in net earnings due to the litigation settlement.
- 5Inventories increased significantly by $952.3 million, and trade receivables grew by $316.4 million, contributing to a working capital increase to $5.3 billion.
- 6Cardinal Health announced the completion of the Syncor acquisition on January 1, 2003, valued at approximately $781 million plus $120 million in debt assumption.
- 7The company continued its share repurchase program, authorizing an additional $500 million repurchase plan in January 2003 and having repurchased $451 million under a prior authorization by December 31, 2002.